An Overview to Candidiasis - A Candida Infection
Keywords:
Candidiasis, Candida, Treatment, ClassificationAbstract
Microbes are basically very small living things that human eye is not capable to see but are only visible under a microscope. Candida is a fungal contamination in body as it is a type of yeast. Candidiasis is entitled as the yeast contagion, due to the infecting agent a yeast, Candida. Candida albicans are the pathogens that are of much significance which are present everywhere and mostly reside along side plentiful bacteria near mouth, gastrointestinal tract and vagina. Wilkinson was the first person to describe candidiasis in 1849. Candidiasis of the mouth is termed as Thrush. Those areas of the skin where there is very less ventilation and are uncommonly wet develop infection of the skin called Cutaneous candidiasis. When Fungi invades inside the body, enters the blood stream and spreads everywhere inside it is called deep Candidiasis. Treatment methodology are different for each case. Natural prevention is mandatory to safe yourself from being a victim to disease.
How to cite this article:
Qadir MI, Asif H. An Overview to Candidiasis - A Candida infection. Int J Adv Res Micro Biol Immunol 2019; 2(1): 31-33.
References
Sohnle PG. Superficial Fungal Infections. Fungal Infections and Immune Responses. Infectious Agents
and Pathogenesis. Murphy JW, Friedman H, Bendinelli M. (eds). Springer, Boston MA 1993: 7-28.
Falagas ME, Betsi GI, Athanasiou S. Probiotics for prevention of recurrent vulvovaginal candidiasis:
a review. Journal of Antimicrobial Chemotherapy 2006; 58(2): 266-272.
Andes DR, Safdar N, Baddley JW et al. Impact of treatment strategy on outcomes in patients with
candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized
trials. Clinical infectious diseases 2012; 54(8): 1110-1122.
Pappas PG, Rex JH, Sobel JD et al. Guidelines for treatment of candidiasis. Clinical infectious diseases
; 38(2): 161-189.
Akpan A, Morgan R. Oral candidiasis. Post-graduate medical journal 2002; 78(922): 455-459.
Richard CA, Clancy CJ. Candida and candidiasis. American Society for Microbiology Press 2011.
Kabir MA, Hussain MA, Ahmad Z. Candida albicans: AModel Organism for Studying Fungal Pathogens. ISRN Microbiology 2012; 1: 1-16.
Kabir AM, Hussain MA, Ahmad Z. Candida albicans: A Model Organism for Studying Fungal Pathogens. ISRN
Microbiology 2012.
Spampinato C, Leonardi D. Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and
Alternative Antifungal Agents. BioMed Research International 2013.
Kabir AM, Ahmad Z. Candida Infections and Their Prevention. ISRN Prev Med 2013.
Akpan A, Morgan R. Oral candidiasis. Postgraduate medical journal 2002; 78(922): 455-9.
Cornelius CJ, Nguyen MH. Diagnosing invasive candidiasis. Journal of clinical microbiology 2018; 56(5).
Arturo C, Pirofski LA. A Therapeutic Vaccine for Recurrent Vulvovaginal Candidiasis 2018: 1937-1939.
Farhan MA, Moharram AM, SalahT et al. Types of yeasts that cause vulvovaginal candidiasis in chronic users of
corticosteroids. Medical mycology 2018.
John RH, Walsh TJ, Jack SD et al. Practice guidelines for the treatment of candidiasis. Clinical infectious
diseases 2000; 30(4): 662-68.
Jack SD, Faro S, Force RW et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic
considerations. American journal of obstetrics and gynecology 1998; 178(2): 203-211.
Wall G, Jauregui MD, Bonifacio BV et al. Candida albicans biofilm growth and dispersal: contributions
to pathogenesis. Current opinion in microbiology 2019; 52: 1-6.
Peter G. John PH, Jack RD et al. Guidelines for Treatment of Candidiasis. Clinical Infectious Diseases 2004; 38(2):
-189.
Flevari A, Theodorakopoulou M, Velegraki A et al. George Dimopoulos Clin Interv Aging 2013; 8: 1199-
Jennings JE, Brush CG. Research on women entrepreneurs: challenges to (and from) the broader
entrepreneurship literature? The Academy of Management Annals 2013; 7(1): 663-715.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 International Journal of Advanced Research in Microbiology & Immunology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
Important
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.
